These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26537861)

  • 21. Pathophysiology of Bone Fragility in Patients with Diabetes.
    Palermo A; D'Onofrio L; Buzzetti R; Manfrini S; Napoli N
    Calcif Tissue Int; 2017 Feb; 100(2):122-132. PubMed ID: 28180919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone fragility in patients with diabetes mellitus: A consensus statement from the working group of the Italian Diabetes Society (SID), Italian Society of Endocrinology (SIE), Italian Society of Gerontology and Geriatrics (SIGG), Italian Society of Orthopaedics and Traumatology (SIOT).
    Napoli N; Incalzi RA; De Gennaro G; Marcocci C; Marfella R; Papalia R; Purrello F; Ruggiero C; Tarantino U; Tramontana F; Conte C
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1375-1390. PubMed ID: 33812734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fracture Risk Assessment in Patients With Diabetes Mellitus.
    Poiana C; Capatina C
    J Clin Densitom; 2017; 20(3):432-443. PubMed ID: 28716499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes Mellitus: Does it Affect Bone?
    Schwartz AV
    Calcif Tissue Int; 2003 Dec; 73(6):515-9. PubMed ID: 14517715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of impaired bone strength in type 1 and 2 diabetes.
    Merlotti D; Gennari L; Dotta F; Lauro D; Nuti R
    Nutr Metab Cardiovasc Dis; 2010 Nov; 20(9):683-90. PubMed ID: 20934862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: The mechanisms and roles of increased bone marrow adiposity.
    Ali D; Tencerova M; Figeac F; Kassem M; Jafari A
    Front Endocrinol (Lausanne); 2022; 13():981487. PubMed ID: 36187112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone Fragility in Diabetes and its Management: A Narrative Review.
    Leungsuwan DS; Chandran M
    Drugs; 2024 Sep; 84(9):1111-1134. PubMed ID: 39103693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of mineral and bone disorders in the development and progression of cardiac and renal pathology in patients with type 1 diabetes mellitus of long duration.
    Biragova MS; Gracheva SA; Glazunova AM; Martynov SA; Ulaynova IN; Ilyin AV; Philippov YI; Musaeva GM; Shamkhalova MS; Shestakova MV
    Diabetes Res Clin Pract; 2016 Aug; 118():29-37. PubMed ID: 27240104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiological and pathophysiological bone turnover - role of the immune system.
    Weitzmann MN; Ofotokun I
    Nat Rev Endocrinol; 2016 Sep; 12(9):518-32. PubMed ID: 27312863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diabetes increases the risk of fractures].
    Starup-Linde J; Karahasanovic A; Vestergaard P; Eiken P
    Ugeskr Laeger; 2015 Nov; 177(49):V08150663. PubMed ID: 26651553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone mineral content and bone density is lower in adolescents with type 1 diabetes: A brief report from the RESISTANT and EMERALD studies.
    Kaur H; Joshee P; Franquemont S; Baumgartner A; Thurston J; Pyle L; Nadeau KJ; Shah VN
    J Diabetes Complications; 2018 Oct; 32(10):931-933. PubMed ID: 29980432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Usefulness of metformin in diabetes-related bone disease].
    Kanazawa I
    Clin Calcium; 2009 Sep; 19(9):1319-25. PubMed ID: 19721204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Icariin Prevents Diabetes-Induced Bone Loss in Rats by Reducing Blood Glucose and Suppressing Bone Turnover.
    Qi S; He J; Zheng H; Chen C; Lan S
    Molecules; 2019 May; 24(10):. PubMed ID: 31096652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone disorders associated with diabetes mellitus and its treatments.
    Cortet B; Lucas S; Legroux-Gerot I; Penel G; Chauveau C; Paccou J
    Joint Bone Spine; 2019 May; 86(3):315-320. PubMed ID: 30098423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fragility fractures and bone mineral density in male patients affected by type 1 and type 2 myotonic dystrophy.
    Passeri E; Sansone VA; Sconfienza LM; Messina C; Meola G; Corbetta S
    Neuromuscul Disord; 2020 Jan; 30(1):28-34. PubMed ID: 31902642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes mellitus and osteoporosis.
    Sealand R; Razavi C; Adler RA
    Curr Diab Rep; 2013 Jun; 13(3):411-8. PubMed ID: 23471742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
    Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
    J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoporosis and risk of fracture in patients with diabetes: an update.
    Montagnani A; Gonnelli S; Alessandri M; Nuti R
    Aging Clin Exp Res; 2011 Apr; 23(2):84-90. PubMed ID: 21743287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of diabetes therapy on bone: A clinical perspective.
    Kheniser KG; Polanco Santos CM; Kashyap SR
    J Diabetes Complications; 2018 Jul; 32(7):713-719. PubMed ID: 29747995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mouse models of type 1 diabetes and their use in skeletal research.
    Kalaitzoglou E; Fowlkes JL; Thrailkill KM
    Curr Opin Endocrinol Diabetes Obes; 2022 Aug; 29(4):318-325. PubMed ID: 35749285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.